A multistakeholder roundtable discussion, moderated by Maria Theodoulou, MD, of New York Oncology Hematology, focused on HER2-positive breast cancer diagnosis, treatment, and management. Dr. Theodoulou was joined by Andrew D. Seidman, MD, Melissa Carver, MSN, ARNP, AOCN, and Christine McGinn, MSN, APRN, ACNP-BC.
In this segment of the roundtable series, the panelists discuss how nurses can find opportunities to connect with patients who are receiving treatment for breast cancer, and how reducing treatment time benefits patients and clinics.